
Usual rivals Sanofi and GlaxoSmithKline have said they are to put aside competition with the forging of a new “unprecedented …

US President Donald Trump has announced the US will stop funding the World Health Organization due to allegations that they …

A judge has ruled that Gilead Sciences owe Bristol-Myers Squibb (BMS) additional funds after infringing on one of the company’s …

23-year-old US student Madelyn Lazra recently graduated with a BA in Business Law and certification in International Business, and is …

As the R&D race against COVID-19 continues, AstraZeneca is poised to launch a global, multicentre clinical trial to test its …

The British government has confirmed it will go ahead in utilizing an app that will warn people if they have …

Gilead has provided an update on its ongoing efforts against the novel coronavirus, revealing data from a cohort analysis of …

A chloroquine study investigating its effects in treating the COVID-19 coronavirus in Brazil has been postponed for safety reasons. It …

The world looks for a coronavirus cure as Inovio begins human trials for a vaccine while another vaccine is in …

Dr Lisa von Moltke has left Aklermes and has joined Seres Therapeutics as its new Chief Medical Officer. Chief Executive …

Circassia Pharmaceuticals has announced its decision to break away from a partnership it forged with AstraZeneca UK back in 2017 …

Pfizer and Eli Lilly have defeated a class action lawsuit seeking billions in damages over claims that Viagra and Cialis …

The American Association of Poison Control Centers (AAPCC) has said there has been an increase in people abusing the anti-malaria …

Roche has signed a new partnership with Arrakis Therapeutics in a bid to drive discovery of RNA-targeted small molecule (rSM) …

Global healthcare communications consultancy 90TEN has been acquired by Envision Pharma Group, it has been revealed. 90TEN said that it …

StrideBio have announced the appointment of Maritza McIntyre Ph.D., as its first Chief Development Officer. The newly created role will …

Sage Therapeutics has revealed a radical restructuring effort to cut costs and “enable the company to advance its corporate strategy …

The Centers for Disease Control and Prevention (CDC) confirms that COVID-19 is less severe in children than adults. The report, …

Eli Lilly announced that it will limit out of pocket costs for insulin to $35 per month to offset the …

Gilead and microbiome science specialist Second Genome have announced they are to partner up to advance a selection of the …